P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5′-n-methyluronamide in human leukemia cells

Induction of apoptosis by A3 adenosine receptor agonist N6-(3-iodobenzyl)-adenosine-5′-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism

(2010) P. Mlejnek et al.   Acta Physiologica

Halogenation of N6-benzyladenosine decreases its cytotoxicity in human leukemia cells

(2010) Petr Dolezel et al.   TOXICOLOGY IN VITRO

Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-κB signalling pathway in thyroid cancer cells

(2009) Silvana Morello et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)

(2008) Ruoping Tang et al.   BMC CANCER

Serine protease inhibitorsN-α-Tosyl-L-Lysinyl-Chloromethylketone (TLCK) andN-Tosyl-L-Phenylalaninyl-Chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases

(2007) Ivo Frydrych et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The A3 adenosine receptor: An enigmatic player in cell biology

(2007) Stefania Gessi et al.   PHARMACOLOGY & THERAPEUTICS